Also trades as: 2552.HK (HKSE) · $vol 1M
HUMDF OTC
Hua Medicine (Shanghai) Ltd.
1W: +0.0%
1M: -13.7%
3M: -13.7%
YTD: -28.5%
1Y: -28.5%
3Y: -34.8%
$0.29
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$418M
-147.0% ▼
Capital Expenditures
$4M
+60.8% ▲
5Y CAGR: -17.8%
Free Cash Flow
-$422M
-148.0% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$321M
-133.1% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$393M | -$326M | -$204M | -$211M | -$250M |
| Depreciation & Amort. | $18M | $32M | $32M | $36M | $35M |
| Stock-Based Comp. | $59M | $33M | $21M | $24M | $12M |
| Change in Working Capital | $272M | -$19M | -$27M | $1.1B | -$108M |
| Other Non-Cash Items | -$8M | -$2M | -$53M | -$91M | -$106M |
| Operating Cash Flow | -$21M | -$273M | -$230M | $889M | -$418M |
| — Investing Activities — | |||||
| Capital Expenditures | -$26M | -$67M | -$27M | -$10M | -$3M |
| Acquisitions (Net) | $0 | $0 | -$706K | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $12M | -$1M | $23M | $18M | $13M |
| Investing Cash Flow | -$14M | -$68M | -$5M | $8M | $10M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$15M | -$16M | $11M | $90M | $113M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | -$88K | -$31M | -$31M |
| Financing Cash Flow | -$7M | -$6M | $21M | $69M | $84M |
| Net Change in Cash | -$74M | -$357M | -$185M | $970M | -$321M |
| Cash End of Period | $1.0B | $675M | $491M | $1.5B | $1.1B |
| Free Cash Flow | -$47M | -$340M | -$258M | $880M | -$422M |